Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

The adipose-derived lineage-negative cells are enriched mesenchymal stem cells and promote limb ischemia recovery in mice.

Qin Y, Zhou P, Zhou C, Li J, Gao WQ.

Stem Cells Dev. 2014 Feb 15;23(4):363-71. doi: 10.1089/scd.2013.0212. Epub 2013 Nov 7.

PMID:
24083854
2.

Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.

Madonna R, Taylor DA, Geng YJ, De Caterina R, Shelat H, Perin EC, Willerson JT.

Circ Res. 2013 Sep 13;113(7):902-14. doi: 10.1161/CIRCRESAHA.113.301690. Epub 2013 Jun 18.

3.

Human adipose tissue-resident monocytes exhibit an endothelial-like phenotype and display angiogenic properties.

Navarro A, Marín S, Riol N, Carbonell-Uberos F, Miñana MD.

Stem Cell Res Ther. 2014 Apr 14;5(2):50. doi: 10.1186/scrt438.

4.

Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice.

Yan J, Tie G, Wang S, Messina KE, DiDato S, Guo S, Messina LM.

J Am Heart Assoc. 2012 Dec;1(6):e002238. doi: 10.1161/JAHA.112.002238. Epub 2012 Dec 19.

5.

Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation.

Akimoto K, Kimura K, Nagano M, Takano S, To'a Salazar G, Yamashita T, Ohneda O.

Stem Cells Dev. 2013 May 1;22(9):1370-86. doi: 10.1089/scd.2012.0486. Epub 2013 Feb 4.

6.

Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization.

Xu Y, Meng H, Li C, Hao M, Wang Y, Yu Z, Li Q, Han J, Zhai Q, Qiu L.

Stem Cells Dev. 2010 Oct;19(10):1511-22. doi: 10.1089/scd.2009.0321.

PMID:
20170363
7.
8.

VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity.

Du W, Li X, Chi Y, Ma F, Li Z, Yang S, Song B, Cui J, Ma T, Li J, Tian J, Yang Z, Feng X, Chen F, Lu S, Liang L, Han ZB, Han ZC.

Stem Cell Res Ther. 2016 Apr 4;7:49. doi: 10.1186/s13287-016-0297-0.

9.

Comparative characterization of mesenchymal stromal cells from multiple abdominal adipose tissues and enrichment of angiogenic ability via CD146 molecule.

Lee NE, Kim SJ, Yang SJ, Joo SY, Park H, Lee KW, Yang HM, Park JB.

Cytotherapy. 2017 Feb;19(2):170-180. doi: 10.1016/j.jcyt.2016.11.002. Epub 2016 Dec 23.

PMID:
28024875
10.

Effect of brain-derived neurotrophic factor on mesenchymal stem cell-seeded electrospinning biomaterial for treating ischemic diabetic ulcers via milieu-dependent differentiation mechanism.

He S, Shen L, Wu Y, Li L, Chen W, Hou C, Yang M, Zeng W, Zhu C.

Tissue Eng Part A. 2015 Mar;21(5-6):928-38. doi: 10.1089/ten.TEA.2014.0113. Epub 2014 Dec 11.

PMID:
25316594
11.

Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia.

Moon MH, Kim SY, Kim YJ, Kim SJ, Lee JB, Bae YC, Sung SM, Jung JS.

Cell Physiol Biochem. 2006;17(5-6):279-90. Epub 2006 Jun 20.

12.

Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice.

Amin AH, Abd Elmageed ZY, Nair D, Partyka MI, Kadowitz PJ, Belmadani S, Matrougui K.

Lab Invest. 2010 Jul;90(7):985-96. doi: 10.1038/labinvest.2010.86. Epub 2010 May 3.

13.

Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method.

Ishii M, Shibata R, Numaguchi Y, Kito T, Suzuki H, Shimizu K, Ito A, Honda H, Murohara T.

Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2210-5. doi: 10.1161/ATVBAHA.111.231100. Epub 2011 Jul 14.

14.

Overexpression of Gremlin1 in Mesenchymal Stem Cells Improves Hindlimb Ischemia in Mice by Enhancing Cell Survival.

Xiang Q, Hong D, Liao Y, Cao Y, Liu M, Pang J, Zhou J, Wang G, Yang R, Wang M, Xiang AP.

J Cell Physiol. 2017 May;232(5):996-1007. doi: 10.1002/jcp.25578. Epub 2016 Dec 20.

PMID:
27579673
15.
16.

Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives.

Planat-Benard V, Silvestre JS, Cousin B, André M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Pénicaud L, Casteilla L.

Circulation. 2004 Feb 10;109(5):656-63. Epub 2004 Jan 20.

17.

Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.

Koch JM, D'Souza SS, Schwahn DJ, Dixon I, Hacker TA.

Cytotherapy. 2016 Feb;18(2):219-28. doi: 10.1016/j.jcyt.2015.10.013. Epub 2015 Dec 28.

PMID:
26740280
18.

Diabetic Mesenchymal Stem Cells Are Ineffective for Improving Limb Ischemia Due to Their Impaired Angiogenic Capability.

Kim H, Han JW, Lee JY, Choi YJ, Sohn YD, Song M, Yoon YS.

Cell Transplant. 2015;24(8):1571-84. doi: 10.3727/096368914X682792. Epub 2014 Jul 8.

19.

Serially Transplanted Nonpericytic CD146(-) Adipose Stromal/Stem Cells in Silk Bioscaffolds Regenerate Adipose Tissue In Vivo.

Frazier TP, Bowles A, Lee S, Abbott R, Tucker HA, Kaplan D, Wang M, Strong A, Brown Q, He J, Bunnell BA, Gimble JM.

Stem Cells. 2016 Apr;34(4):1097-111. doi: 10.1002/stem.2325. Epub 2016 Mar 9.

20.

Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy.

Schwarz TM, Leicht SF, Radic T, Rodriguez-Arabaolaza I, Hermann PC, Berger F, Saif J, Böcker W, Ellwart JW, Aicher A, Heeschen C.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):e13-21. doi: 10.1161/ATVBAHA.111.239822. Epub 2011 Dec 22. Erratum in: Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):e36.

Supplemental Content

Support Center